Security Snapshot

U S PHYSICAL THERAPY INC /NV - Common Stock (USPH) Institutional Ownership

CUSIP: 90337L108

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

228

Shares (Excl. Options)

16,053,966

Price

$74.96

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+51,538
Value change
+$3,412,914
Number of holders
228
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
15,128,210
SEC-reported price per share
$68.68
Insider filing price
$68.68
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • USPH - U S PHYSICAL THERAPY INC /NV - Common Stock is tracked under CUSIP 90337L108.
  • 228 institutions reported positions in Q1 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 228 to 44 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $1,203,770,157 to $40,462,115.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 228 institutions filings for Q1 2026.

Open SEC evidence

Security key

90337L108

Latest holder period

Q1 2026

13F holders

228

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
USPH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% $169,079,035 2,162,136 BlackRock, Inc. 30 Jun 2025
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 8% -18% $103,934,986 -$23,473,565 1,212,494 -18% Kayne Anderson Rudnick Investment Management, LLC 31 Dec 2025
MORGAN STANLEY 5.9% $60,006,488 889,644 Morgan Stanley 31 Dec 2024
Copeland Capital Management, LLC 5.5% +6.6% $64,444,355 +$3,905,716 836,831 +6.5% Copeland Capital Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $58,731,373 777,590 Vanguard Capital Management 31 Mar 2026

As of 31 Mar 2026, 228 institutional investors reported holding 16,053,966 shares of U S PHYSICAL THERAPY INC /NV - Common Stock (USPH). This represents 106% of the company’s total 15,128,210 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
83%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 2,208,511 +0.39% 0% $165,549,973
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 7% 1,065,856 -12% 0.23% $79,896,590
MORGAN STANLEY 6.6% 1,002,468 -0.09% 0% $75,145,131
BAHL & GAYNOR INC 5.6% 845,388 +28% 0.32% $63,370,284
Copeland Capital Management, LLC 5.5% 836,831 +6.5% 1.4% $62,728,945
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 664,062 0% 0% $49,778,088
STATE STREET CORP 4.3% 648,387 -0.01% 0% $48,899,403
BANK OF AMERICA CORP /DE/ 3.7% 554,621 +11% 0% $41,574,416
DIMENSIONAL FUND ADVISORS LP 3.4% 507,394 +3.2% 0.01% $38,034,586
SOUTHERNSUN ASSET MANAGEMENT, LLC 2.9% 439,904 -8.3% 4.8% $32,975,204
Boston Trust Walden Corp 2.6% 400,109 -12% 0.25% $29,992,171
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.5% 377,863 +1.9% 0.09% $28,324,610
GW&K Investment Management, LLC 2.4% 368,678 +1.9% 0.24% $27,637,000
GEODE CAPITAL MANAGEMENT, LLC 2.4% 365,955 +3% 0% $27,437,214
AMERICAN CENTURY COMPANIES INC 2.2% 336,447 +26% 0.01% $25,220,329
VANGUARD PORTFOLIO MANAGEMENT LLC 2.1% 312,309 0% 0% $23,410,683
ENVESTNET ASSET MANAGEMENT INC 1.8% 273,109 +0.95% 0.01% $20,472,233
SCHRODER INVESTMENT MANAGEMENT GROUP 1.7% 256,515 -30% 0.02% $19,184,757
Point72 Asset Management, L.P. 1.6% 241,402 -37% 0.03% $18,095,494
NORTHERN TRUST CORP 1.4% 210,928 -1.6% 0% $15,811,163
CRAWFORD INVESTMENT COUNSEL INC 1% 151,877 +2.5% 0.19% $11,384,725
FMR LLC 0.98% 148,034 +14% 0% $11,096,603
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.97% 146,968 -0.62% 0% $11,016,721
Rockefeller Capital Management L.P. 0.89% 134,140 -25% 0.02% $10,110,886
ROYAL BANK OF CANADA 0.88% 133,777 +22% 0% $10,029,000

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q1 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 588,352 $40,462,115 -$4,037,118 $68.68 44
2026 Q1 16,053,966 $1,203,770,157 +$3,412,914 $74.96 228
2025 Q4 16,007,650 $1,251,280,500 -$3,483,427 $78.09 229
2025 Q3 16,025,734 $1,361,095,362 +$39,363,325 $84.95 244
2025 Q2 15,603,014 $1,220,352,681 +$28,791,118 $78.20 237
2025 Q1 15,293,795 $1,107,121,992 -$19,791,948 $72.36 252
2024 Q4 15,565,122 $1,381,034,235 +$12,224,751 $88.71 254
2024 Q3 15,433,476 $1,305,757,796 +$18,383,601 $84.63 254
2024 Q2 15,172,253 $1,402,254,310 -$59,249,178 $92.42 240
2024 Q1 15,618,754 $1,762,911,037 +$17,934,190 $112.87 234
2023 Q4 15,447,185 $1,438,773,106 +$3,869,053 $93.14 211
2023 Q3 15,398,086 $1,412,523,676 +$4,037,253 $91.73 216
2023 Q2 15,234,561 $1,848,475,452 +$186,901,768 $121.39 210
2023 Q1 13,701,294 $1,341,722,062 +$28,779,416 $97.91 195
2022 Q4 13,436,114 $1,088,773,930 +$71,739,919 $81.03 194
2022 Q3 13,124,739 $998,171,735 -$72,742,621 $76.02 189
2022 Q2 13,042,508 $1,423,973,455 +$34,859,639 $109.20 203
2022 Q1 12,815,293 $1,273,306,835 +$8,895,292 $99.45 203
2021 Q4 12,738,854 $1,217,788,483 -$20,797,020 $95.55 205
2021 Q3 12,685,017 $1,403,954,486 -$3,110,434 $110.60 203
2021 Q2 12,698,610 $1,471,332,128 +$13,558,739 $115.87 213
2021 Q1 12,599,376 $1,311,957,414 -$14,349,614 $104.10 206
2020 Q4 12,764,246 $1,535,159,218 -$22,751,760 $120.25 197
2020 Q3 12,985,104 $1,128,051,401 -$46,160,851 $86.88 176
2020 Q2 13,515,168 $1,094,651,503 +$19,402,988 $81.02 180
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .